Kelly Lawrence W & Associates Inc. CA Buys Shares of 2,685 CVS Health Co. (NYSE:CVS)

Kelly Lawrence W & Associates Inc. CA purchased a new position in shares of CVS Health Co. (NYSE:CVS – Get Rating) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 2,685 shares of the pharmacy operator’s stock, valued at approximately $277,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. American Money Management LLC boosted its stake in CVS Health by 34.0% in the fourth quarter. American Money Management LLC now owns 3,659 shares of the pharmacy operator’s stock valued at $377,000 after acquiring an additional 929 shares during the last quarter. Epoch Investment Partners Inc. boosted its position in shares of CVS Health by 5.9% in the 4th quarter. Epoch Investment Partners Inc. now owns 632,969 shares of the pharmacy operator’s stock worth $65,297,000 after purchasing an additional 35,266 shares during the last quarter. Laraway Financial Inc acquired a new stake in shares of CVS Health during the fourth quarter worth $260,000. Sequoia Financial Advisors LLC increased its holdings in CVS Health by 239.1% in the fourth quarter. Sequoia Financial Advisors LLC now owns 113,656 shares of the pharmacy operator’s stock valued at $11,725,000 after purchasing an additional 80,141 shares during the last quarter. Finally, Mission Wealth Management LP boosted its holdings in CVS Health by 28.9% during the fourth quarter. Mission Wealth Management LP now owns 3,900 shares of the pharmacy operator’s stock worth $402,000 after buying an additional 875 shares during the last quarter. Institutional investors and hedge funds own 78.00% of the company’s stock.

In other news, EVP Daniel P. Finke sold 55,359 shares of the firm’s stock in a transaction that occurred on Monday, April 4th. The stock was sold at an average price of $100.13, for a total value of $5,543,096.67. Following the completion of the sale, the executive vice president now directly owns 3,098 shares of the company’s stock, valued at $310,202.74. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Prem S. Shah sold 4,624 shares of the business’s stock in a transaction that occurred on Thursday, March 17th. The stock was sold at an average price of $106.65, for a total value of $493,149.60. The disclosure for this sale can be found here. In the last quarter, insiders sold 82,283 shares of company stock valued at $8,376,142. Corporate insiders own 0.69% of the company’s stock.

CVS has been the topic of several recent analyst reports. StockNews.com started coverage on shares of CVS Health in a research note on Thursday, March 31st. They set a “strong-buy” rating on the stock. Raymond James lowered shares of CVS Health from a “strong-buy” rating to an “outperform” rating and boosted their price target for the company from $115.00 to $120.00 in a report on Friday, February 11th. Tigress Financial raised their price objective on CVS Health from $122.00 to $125.00 in a research note on Thursday, April 7th. BMO Capital Markets boosted their target price on CVS Health from $108.00 to $120.00 in a research note on Thursday, February 10th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on CVS Health from $110.00 to $113.00 in a research report on Thursday, May 5th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $114.90.

NYSE:CVS traded down $0.85 on Thursday, hitting $93.17. 545,918 shares of the company’s stock were exchanged, compared to its average volume of 5,742,266. The firm has a 50-day moving average price of $102.61 and a 200-day moving average price of $101.18. CVS Health Co. has a 52 week low of $79.33 and a 52 week high of $111.25. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.88 and a quick ratio of 0.62. The company has a market cap of $122.17 billion, a P/E ratio of 15.62, a price-to-earnings-growth ratio of 1.56 and a beta of 0.78.

CVS Health (NYSE:CVS – Get Rating) last issued its quarterly earnings results on Wednesday, May 4th. The pharmacy operator reported $2.22 EPS for the quarter, beating the consensus estimate of $2.14 by $0.08. CVS Health had a return on equity of 15.33% and a net margin of 2.67%. The firm had revenue of $76.83 billion during the quarter, compared to analysts’ expectations of $75.30 billion. During the same period in the prior year, the firm posted $2.04 earnings per share. The business’s quarterly revenue was up 11.2% compared to the same quarter last year. On average, research analysts expect that CVS Health Co. will post 8.32 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Monday, May 2nd. Shareholders of record on Friday, April 22nd were given a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a yield of 2.36%. The ex-dividend date was Thursday, April 21st. CVS Health’s dividend payout ratio (DPR) is currently 36.54%.

CVS Health Company Profile (Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Recommended Stories